Cure.

?? Cure & Catalytic Impact Foundation are excited to announce the top six early-stage company finalists addressing a disease or condition predominantly, differently, or exclusively affecting women. All six companies are coming to NYC to pitch their companies live at the Power of X Summit: Solutions to an Untapped Market on Tuesday, March 25th, in front of investors and innovators. Congratulations to Maipl Therapeutics, Inc., Flourish Care, DeepLook Medical, Limax Biosciences, inSoma Bio, and LunaJoy Health. This is your last chance if you haven't registered for the Power of X Summit yet. Use discount code LASTCALL: https://lnkd.in/exgvH-Wv

“For a successful startup, you need scientific leadership with a breakthrough innovation, commercial leadership that understands the market, and the data to make a compelling business case,” Cure CEO Seema Kumar. “Too often, these elements exist in isolation from one another.” Cure. aims to be the connective tissue between these worlds – bridging gaps between startups and investors, young innovators and experienced professionals, researchers and the private sector.

?? 5 Days Left! ?? We are thrilled to announce that?Keara S., CEO of?Sauber Capital,?will join us to discuss?Building an Investment Case: Translational and Commercialization Experience. With more than two decades of experience, Keara is a seasoned executive with a strong biotech, venture capital, and finance background. She began her career at GSK before transitioning into leadership roles in the biopharmaceutical industry, including serving as CEO of a biosimilar company. As a co-founder and investor, Keara has built and scaled multiple ventures, leveraging her capital stacks, fundraising, and strategic growth expertise. She is actively involved in venture capital through her work with Gaingels, focusing on early-stage investments, company creation, and portfolio growth. ???Learn more about our Speakers & Register Today with our Special Discount Code "LASTCALL" https://lnkd.in/earzekFG #womenshealth #powerofx #womenshealthinvestment

A novel IV treatment yields first-of-its-kind genetic correction in living patients, signaling a new era in precision medicine. Read more about what scientists call a medical first, from Cambridge-based Beam Therapeutics who has successfully corrected a disease-causing genetic mutation in living patients, demonstrating a new approach for people with a rare but devastating condition that destroys both lungs and liver. https://lnkd.in/dBrX5sFF

?? One Week Left! ?? We’re counting down to the Power of X Summit: Solutions for an Untapped Market, happening March 24-25, 2025! And we’re excited to announce that Viq Pervaaz, SVP, Life Sciences & Healthcare at the New York City Economic Development Corporation, will join us on stage! Viq will share how #NYC is leveraging its world-class resources to address the unmet medical needs of women—and how the city is scaling programs, maximizing data, and improving healthcare delivery to drive better outcomes for local communities. #womenshealth #healthequity Check out the Full Agenda & Register Today: https://lnkd.in/exgvH-Wv

This past week, at investment banking firm Jefferies recent biotech conference in Miami, a policy panel featuring John F. Crowley CEO of the Biotechnology Innovation Organization, Joel White of Horizon Government Affairs, and Raghav Aggarwal from BGR Group said the political shift under President Trump could ultimately benefit the biotech sector. Read more about why industry leaders and analysts predict policy shifts could benefit innovation & drug pricing reform. https://lnkd.in/e3Xj3pmf

What if women's ovaries could stay healthier, longer? Read more on how NY-based Celmatix Therapeutics is developing a first-in-class therapy to extend ovarian function—potentially reducing risks of heart disease, osteoporosis, & cognitive decline. A game-changer for women's health & aging! #womenshealth #therapeutics Piraye Beim

??? Power of X Summit: Solutions for an Untapped Market -- Panel Announcement ?? Advocating for Lasting Impact ?? How do we keep women’s health at the top of the agenda? Join our panel of experts to explore how companies, advocates, and policymakers can drive lasting change through research, funding & collaboration. Panelists will share expert strategies & solutions to build upon the women's health movement: ?? Greg Simon ?? E. Cartier Esham, Ph.D. ?? Jennifer Luray ?? Seileen Mullen ?? Liz Powell ?? Register Today: https://lnkd.in/earzekFG #womenshealth #publichealth #publicpolicy #womensresearch #powerofX

?? SPEAKER ANNOUNCEMENT With autoimmune diseases affecting approximately 8% of the U.S. population, 78% of whom are women. Rekha Kumar, M.D, M.S., Associate Professor of Clinical Medicine at Weill Cornell Medicine, will help us navigate and identify why women are more prone to #autoimmunediseases like #Rheumatoidarthritis, #Lupus, #Psoriasis, and #Psoriaticarthritis. Dr. Rekha Kumar is recognized as an international leader in the field of Obesity Medicine. She is a practicing endocrinologist in New York City and served as the former medical director of the American Board of Obesity Medicine. Dr. Kumar's expertise includes the clinical assessment of patients' obesity and metabolic syndrome, the effect of obesity on reproductive health and fertility, and thyroid disease. Alongside her clinical practice, Dr. Kumar serves as the Head of Medical Affairs for a healthcare technology company called Found, which focuses on expanding access to obesity care. ???Learn more about our speakers & register today: https://lnkd.in/earzekFG #autoimmune #womenshealth #powerofx #womenshealthinvestment

There is no standard path from bench to bedside, says Tingting Zhang-Kharas, PhD Head of Johnson & Johnson’s JLABS program in the Northeast and mid-Atlantic states. No two innovations are alike, competitive landscapes differ and skeptical investors often dictate scientific milestones – including specific experiments – that must be achieved before they’re willing to back the product’s development, she said. Read more from Cure writer Steve Sternberg on how Academic institutions and industry leaders are forging new pathways to commercialize cutting-edge research. https://lnkd.in/eX5tXdu9 #AUTM2025